Suppr超能文献

反义磷酰二胺吗啉代寡聚物抑制纯培养物中及小鼠腹膜炎模型中大肠杆菌的生存能力。

Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.

作者信息

Geller Bruce L, Deere Jesse, Tilley Lucas, Iversen Patrick L

机构信息

Department of Microbiology, 220 Nash Hall, Oregon State University, Corvallis, OR 97331-3804, USA.

出版信息

J Antimicrob Chemother. 2005 Jun;55(6):983-8. doi: 10.1093/jac/dki129. Epub 2005 May 4.

Abstract

OBJECTIVES

Antisense phosphorodiamidate morpholino oligomers (PMOs) are synthetic DNA mimics that specifically inhibit gene expression in pure cultures of Escherichia coli. Previously, an 11 base PMO targeted to an essential gene (acpP) for phospholipid biosynthesis was shown to inhibit growth of a pure culture of E. coli AS19, which has an abnormally permeable outer membrane. The objectives of experiments in this report are to show that the AcpP PMO significantly inhibits growth of strain SM105, which has a normal, intact outer membrane, both in pure culture and in infected mice.

METHODS

In pure culture, SM105 was grown in rich broth supplemented with 20 muM AcpP PMO, and growth was monitored by optical density and viable cell count. Mice were infected by intraperitoneal injection with a non-lethal inoculum of either E. coli AS19 or SM105. Following infection, mice were treated intraperitoneally with 300 mug of the 11 base antisense PMO targeted to acpP, a scrambled sequence PMO or PBS.

RESULTS

Growth of SM105 was slower and viable cells were significantly reduced by up to 61% in pure cultures supplemented with AcpP PMO compared with untreated cultures or cultures supplemented with a scrambled sequence PMO. A single dose of AcpP PMO reduced peritoneal cfu of E. coli AS19 about 39- to 600-fold compared with controls at 2, 7, 13 and 23 h after treatment. The same PMO significantly reduced cfu of E. coli SM105 75% compared with controls at 12 h after treatment. However, there was no difference in cfu at 2, 7 or 24 h. A second dose at 24 h again reduced SM105 cfu about 10-fold by 48 h post-infection. In other experiments with infected mice, multiple doses of AcpP PMO sustained the approximately 10-fold reduction in SM105 cfu at 6, 12 and 24 h post-infection. Compared with equivalent (micromolar) doses of ampicillin, AcpP PMO was significantly more effective at all time points. Specificity of PMO inhibition was shown in other experiments by treating infected mice with a PMO targeted to a non-essential reporter gene for luciferase. A luciferase-specific PMO reduced both the amount and activity of luciferase to the same extent, whereas scrambled PMO had no effect.

CONCLUSIONS

An 11 base antisense PMO targeted to acpP significantly inhibited viability of a strain of E. coli with a normal, intact outer membrane both in pure culture and in infected mice. Inhibition by PMOs was sequence-specific.

摘要

目的

反义磷酰二胺吗啉代寡聚物(PMO)是一种合成的DNA模拟物,可特异性抑制大肠杆菌纯培养物中的基因表达。此前,一种靶向磷脂生物合成必需基因(acpP)的11碱基PMO被证明可抑制具有异常通透外膜的大肠杆菌AS19纯培养物的生长。本报告中的实验目的是表明AcpP PMO在纯培养物和感染小鼠中均能显著抑制具有正常完整外膜的SM105菌株的生长。

方法

在纯培养中,将SM105在补充有20μM AcpP PMO的丰富肉汤中培养,并通过光密度和活细胞计数监测生长情况。通过腹腔注射非致死剂量的大肠杆菌AS19或SM105对小鼠进行感染。感染后,对小鼠进行腹腔注射300μg靶向acpP的11碱基反义PMO、乱序序列PMO或PBS。

结果

与未处理的培养物或补充有乱序序列PMO的培养物相比,在补充有AcpP PMO的纯培养物中,SM105的生长较慢,活细胞显著减少高达61%。在治疗后2、7、13和23小时,单剂量的AcpP PMO使大肠杆菌AS19的腹腔cfu比对照组降低约39至600倍。与对照组相比,相同的PMO在治疗后12小时使大肠杆菌SM105的cfu显著降低75%。然而,在2、7或24小时时cfu没有差异。在感染后24小时给予第二剂,到感染后48小时再次使SM105的cfu降低约10倍。在其他感染小鼠的实验中,多剂量的AcpP PMO在感染后6、12和24小时使SM105的cfu持续降低约10倍。与等效(微摩尔)剂量的氨苄青霉素相比,AcpP PMO在所有时间点都显著更有效。在其他实验中,通过用靶向荧光素酶非必需报告基因的PMO治疗感染小鼠,显示了PMO抑制的特异性。一种荧光素酶特异性PMO将荧光素酶的量和活性降低到相同程度,而乱序PMO则没有效果。

结论

靶向acpP的11碱基反义PMO在纯培养物和感染小鼠中均能显著抑制具有正常完整外膜的大肠杆菌菌株的活力。PMO的抑制作用具有序列特异性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验